Display options
Share it on

Clin Mol Pathol. 1995 Jun;48(3):M158-64. doi: 10.1136/mp.48.3.m158.

In situ visualisation of immunoglobulin genes in normal and malignant lymphoid cells.

Clinical molecular pathology

C Carvalho, M Telhada, M do Carmo-Fonseca, L Parreira

Affiliations

  1. Instituto de Histologia e Embriologia, Faculdade de Medicina de Lisboa, Av. Prof Egas Moniz, 1600 Lisbon, Portugal.

PMID: 16695998 PMCID: PMC407950 DOI: 10.1136/mp.48.3.m158

Abstract

Aims-To directly visualise immunoglobulin (Ig) heavy (H) and light chain genes (kappa and lambda) in metaphase chromosomes and interphase nuclei of normal and malignant lymphocytes using small genomic probes targeted to intragenic sequences.Methods-Cytogenetic preparations from phytohaemagglutinin stimulated lymphocytes, B-chronic lymphocytic leukaemia (B-CLL) cells, and a B-prolymphocytic leukaemia (B-PLL) cell line, containing a t(11;14), were hybridised in situ using biotin or digoxigenin labelled plasmid probes. The kappa genes were visualised with a combination of probes for the Ckappa, Jkappa, Vkappa1, and Vkappa2 segments, the lambda genes with a probe containing the Jlambda2-Clambda2, Jlambda3-Clambda3 segments and the H genes with a probe for Clambda2. Hybridisation sites were visualised using appropriate fluorochrome conjugates and images were analysed by digital microscopy.Results-In both normal and malignant lymphoid cells, the kappa and lambda genes were visualised as a single dot signal, whereas the H lambda genes were resolved as either two or three separate signals per chromatid in metaphase chromosomes or per allele in interphase nuclei. In the malignant PLL cells, double hybridisation experiments with a painting library specific for the chromosome 11 showed that the lambda region was retained in the translocated chromosome, with an in situ resolution pattern similar to that of the normal allele.Conclusions-This study shows that a high resolution in situ analysis of the three Ig loci can be efficiently performed with small size genomic probes on both normal and malignant lymphoid cells. Such an approach offers a flexible tool for the molecular characterisations of these loci on chromosomes and individual neoplastic cells.

References

  1. J Exp Med. 1986 Feb 1;163(2):425-35 - PubMed
  2. Cell. 1980 Nov;22(1 Pt 1):197-207 - PubMed
  3. Nature. 1981 Apr 2;290(5805):368-72 - PubMed
  4. Hum Mol Genet. 1992 Nov;1(8):625-32 - PubMed
  5. J Microsc. 1990 May;158(Pt 2):207-14 - PubMed
  6. J Immunol. 1987 Aug 15;139(4):1326-35 - PubMed
  7. Clin Exp Immunol. 1988 Jul;73(1):23-8 - PubMed
  8. Eur J Immunol. 1990 Aug;20(8):1855-63 - PubMed
  9. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9074-8 - PubMed
  10. Science. 1990 Aug 24;249(4971):928-32 - PubMed
  11. Trends Genet. 1991 May;7(5):149-54 - PubMed
  12. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3416-9 - PubMed
  13. Hum Genet. 1988 Nov;80(3):224-34 - PubMed
  14. Cell. 1991 Jan 25;64(2):337-50 - PubMed
  15. Nature. 1983 Jul 14-20;304(5922):172-4 - PubMed
  16. Nature. 1983 Apr 14;302(5909):575-81 - PubMed
  17. Int J Cancer. 1986 Oct 15;38(4):531-8 - PubMed
  18. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5567-71 - PubMed
  19. Genomics. 1989 May;4(4):505-8 - PubMed
  20. J Exp Med. 1982 May 1;155(5):1480-90 - PubMed
  21. Methods Cell Biol. 1991;35:73-99 - PubMed
  22. Science. 1990 Jan 5;247(4938):64-9 - PubMed
  23. Nature. 1982 Dec 23;300(5894):709-13 - PubMed
  24. EMBO J. 1982;1(4):403-7 - PubMed
  25. Cell. 1984 Apr;36(4):801-3 - PubMed
  26. Immunogenetics. 1987;25(1):63-70 - PubMed
  27. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1984-8 - PubMed
  28. Genet Anal Tech Appl. 1991 Feb;8(1):24-35 - PubMed
  29. J Clin Invest. 1987 May;79(5):1291-5 - PubMed
  30. Cell. 1983 Jan;32(1):181-9 - PubMed

Publication Types